Screening for Cognitive Disorders in Multiple Sclerosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier de Gonesse
About this trial
This study aims to identify cognitive problems in adults with multiple sclerosis (MS). MS can affect memory, thinking speed, and spatial skills, which may impact daily life and work. We will use simple and proven tests to check for these difficulties and see how they affect quality of life. The study will include about 60 patients followed at the neurology day hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 years or older
Diagnosed with multiple sclerosis (MS) for at least 6 months according to the 2017 McDonald criteria (SFSEP)
Receiving disease-modifying treatment and followed in the neurology day hospital of CH Gonesse
Disqualifiers
None
Trial population
The study population consists of adult patients (18 years and older) diagnosed with multiple sclerosis for at least six months according to the 2017 McDonald criteria. These patients are currently receiving disease-modifying treatments and are followed at the neurology day hospital of CH Gonesse.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Prevalence of cognitive impairment in patients with multiple sclerosis, assessed by validated cognitive tests (CSCT, RL/RI-16, Figure de REY, HAD scale, SF-12).
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: